Clinical Trials Logo

Filter by:
NCT ID: NCT05548829 Completed - COVID-19 Clinical Trials

COVID RESPONSE STUDY (COVRES)

COVRES
Start date: December 1, 2020
Phase:
Study type: Observational

This study will undertake recruitment of Covid-19 positive hospitalised and non-hospitalised and nursing home patients, hospital and nursing home staff, for whole genome sequencing, human host genomic analyses and viral genomic analyses. This research study will take place across three trust areas in Northern Ireland.

NCT ID: NCT05547204 Completed - Soccer Performance Clinical Trials

Impact of Coffeeberry Extract on Skill Performance During Simulated Match Play in Academy Football Players

Start date: June 30, 2022
Phase: N/A
Study type: Interventional

This study of soccer skill performance has three objectives: 1. Compare effects of coffeeberry (300mg) and placebo ingestion on dribbling speed and precision, passing speed and accuracy, and sprint speed during a full simulated soccer match. 2. Compare effects of coffeeberry (300mg) and placebo ingestion on subjective measures (mental / physical energy and activation-deactivation (feelings or mood) during a full simulated soccer match. 3. Compare effects of coffeeberry (300mg) and placebo ingestion on chlorogenic acid (CGA) and caffeine metabolites in the blood 1-hour post ingestion, and other blood metabolites (glucose/lactate) throughout the simulated soccer match.

NCT ID: NCT05546957 Completed - Healthy Volunteer Clinical Trials

Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants

Start date: January 5, 2023
Phase: N/A
Study type: Interventional

The primary objective of the study is to determine whether aspirin alone or aspirin combined with various doses of rivaroxaban causes subclinical GI blood loss as determined by the HemoQuant assay. The secondary objective of the study is to evaluate the safety and tolerability of aspirin alone or in combination with rivaroxaban to healthy volunteers.

NCT ID: NCT05544981 Completed - Clinical trials for Cardiovascular Diseases

NITRATE-OCT-CIN (Sub-Study of NITRATE-OCT)

NIT-OCT-CIN
Start date: January 2, 2016
Phase: N/A
Study type: Interventional

The NITRATE-OCT:- Contrast Nephropathy Sub-study is a proof-of concept single center, randomized, clinical trial designed to ascertain whether a dietary NO3- approach might prove useful adjunctive therapy improving renal function and reducing CIN in patients with stable angina undergoing elective angioplasty. Objectives: To determine whether dietary NO3- ingestion exerts any effect on the glomerular filtration rate (GFR) after the exposure to contrast media. To determine if dietary NO3- ingestion will decrease the incidence of contrast induced nephropathy. Setting: The patients will be recruited from an on-going clinical trial NITRATE-OCT. This is a study assessing whether the use of dietary NO3- may reduce the incidence of restenosis following elective angioplasty. This study is recruiting patients with stable angina and single/multiple coronary artery stenosis undergoing elective PCI who are haemodynamically stable (systolic BP>100 mmHg). These patients will be recruited at The Barts Heart Centre at St Bartholomew's Hospital. This is one of the biggest centres in the UK, serving a population of almost two million people from The City of London and The North East up to the M25 and is a 24/7 centre performing approximately 3000 angioplasties a year. The study will take place in the Clinical Trials Unit, William Harvey Heart Centre. Target population: A total of 246 patients (male and female, age 18-85) with stable angina as per requirements indicated above. Follow-up will take place in the Clinical Trials Unit, William Harvey Research Institute. Treatment: Patients will be randomised (using an on line randomisation database) to receive 70 ml of a beetroot juice concentrate containing 4-5 mmol nitrate or nitrate-depleted placebo juice concentrate. This intervention will be taken by the patient daily from one day prior to re-establishment of flow with PCI and stent implantation.

NCT ID: NCT05544500 Completed - Cognitive Change Clinical Trials

Immediate and Residual Effects of Functional Chewing Gum on Concentration

Start date: July 5, 2022
Phase: N/A
Study type: Interventional

Previous research suggests that chewing gum may influence several functions including attention and alertness. Gum can also be used as a vehicle for delivering ingredients that have the ability to modulate attention and mood. This study will explore the effects of a functional gum containing a proprietary composition of a herbal extract and vitamins. These effects will be compared to the effects of a basic sugar-free gum and to a tablet which will include the same ingredients as the basic sugar-free gum. Effects will be explored on computerised measures of attention/concentration and via ratings of current mood. The study will assess the immediate effects of chewing gum as well as the effects 1 hour later. There will be an initial remote screening session followed by visits to the laboratory on 4 separate occasions: an introductory/training visit and three active study days.

NCT ID: NCT05538650 Completed - Clinical trials for Stress, Psychological

RCT: Mindfulness for Social Work and Self-care

Start date: October 4, 2022
Phase: N/A
Study type: Interventional

Social work is a stressful occupation with social workers at high risk of job-related stress and burnout. Mindfulness has been evidenced as a promising approach for improving: recovery from stress; behavioural responses to stress; and resilience. The Mindfulness-based social work and self-care programme, a bespoke and innovative online mindfulness programme developed for frontline social workers, have been shown to be effective in improving aspects of psychological and general wellbeing among a social work population. The main aim of the study is to confirm the efficacy of this bespoke, innovative, 6-session Mindfulness Intervention for social workers (MBSWSC) in reducing social worker stress, feelings of burnout, anxiety, low mood and improving well-being. The study will also compare outcomes from the MBSWSC with a briefer, condensed 3 session mindfulness programme (MBSC). The findings of this study will serve to complement and confirm the findings of an initial RCT, but in a post-covid environment.

NCT ID: NCT05534152 Completed - Appetite Clinical Trials

Effect of Sumac on Appetite and Food Intake

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

Sumac, is a spice that is widely used in Turkish, Iranian and Middle Eastern foods. In these regions, the fruit of sumac is used for seasoning or flavouring, as an appetizer and for souring food. This spice has also been used in herbal folk medicine to relieve certain conditions including bowel disorders, anorexia and indigestion. In addition, many studies have shown that sumac contains a high level of antioxidant activity and polyphenol content that may benefit certain diseases such as cancer and diabetes. The aim of this study was to assess the level of the appetite and food intake among young adults in comparison with free living older adults following the consumption of sumac. This was achieved by assessing the amount of food intake during a lunch course and the impact on food intake for the subsequent 12 hours.

NCT ID: NCT05533905 Completed - Multiple Sclerosis Clinical Trials

DECISIve - DiagnosE Using the Central veIn SIgn v1.0

DECISiVE
Start date: December 9, 2019
Phase:
Study type: Observational

DECISIve - DiagnosE using the Central veIn SIgn. A prospective diagnostic superiority study comparing T2* MRI and lumbar puncture in patients presenting with possible Multiple Sclerosis

NCT ID: NCT05532891 Completed - COVID-19 Clinical Trials

Bariatric Surgery and COVID-19

Start date: September 1, 2018
Phase:
Study type: Observational

The National Bariatric Surgical Registry (NBSR) is a prospectively collected database for all patients undergoing elective bariatric surgery in the UK. It was used to identify patients that underwent elective bariatric surgery during the pandemic (one year from 1st April 2020). Characteristics of this group were compared with a pre-pandemic cohort (one year from 1st September 2018).

NCT ID: NCT05532358 Completed - Healthy Volunteers Clinical Trials

A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)

Start date: September 12, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this healthy volunteers drug-drug interaction study is to assess the CYP1A2 and CYP3A4 perpetrator interaction potential and CYP1A2 victim potential of TEV-56286 (anle138b).